Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
21 hedge funds and large institutions have $3.29M invested in Aptose Biosciences, Inc. in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
954% more capital inflows, than outflows
Capital inflows: $1.46M | Capital outflows: $138K
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
31% more funds holding
Funds holding: 16 → 21 (+5)
0.98% more ownership
Funds ownership: 1.56% → 2.55% (+0.98%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$646K |
| 2 |
DRW Securities
Chicago,
Illinois
|
+$368K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$156K |
| 4 |
Two Sigma Advisers
New York
|
+$70.1K |
| 5 |
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
+$59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$102K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$27K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6.38K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$3K |
APTO Hedge Fund Activity: Q2 2018 in Review
21 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q2 2018, worth a combined $3.29M — up 117% from $1.52M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new APTO positions and 2 closed out — a net gain of 6 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $646K. The largest seller was Deutsche Bank, cutting an estimated $102K.
- 21 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q2 2018, up from 16 in Q1 2018.
- Funds reported $3.29M of Aptose Biosciences, Inc. stock for Q2 2018, up 117% quarter-over-quarter.
- 8 funds opened new Aptose Biosciences, Inc. positions in Q2 2018 and 2 closed out, a net change of +6 holders.
- The largest Aptose Biosciences, Inc. buyer in Q2 2018 was Morgan Stanley, an estimated $646K added.
- The largest Aptose Biosciences, Inc. seller in Q2 2018 was Deutsche Bank, an estimated $102K sold.
Based on aggregated 13F filings for Q2 2018.